| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | — | 807,3 k € | -73.0% | 3,0 M € | +0.4% | 3,0 M € | -6.6% | 3,2 M € | +4.4% | 3,1 M € | +4.3% | 2,9 M € | -0.8% | 2,9 M € | +3.0% | 2,9 M € | +24.7% | 2,3 M € | ||||||||||
| EBITDA | 91,6 k € | -16.9% | 110,2 k € | +124.4% | 49,1 k € | +106.9% | -714,5 k € | -10.7% | -645,6 k € | -17.6% | -548,9 k € | +23.9% | -721,2 k € | -66.7% | -432,6 k € | -1666.4% | -24,5 k € | +33.5% | -36,8 k € | -122.5% | 163,4 k € | -59.1% | 399,3 k € | -24.4% | 528,3 k € | +51.8% | 348,0 k € | +26.7% | 274,6 k € | -14.8% | 322,3 k € | -9.7% | 356,9 k € | +67.0% | 213,7 k € | |
| Operating profit | 89,8 k € | -17.4% | 108,8 k € | +125.0% | 48,3 k € | +106.8% | -715,4 k € | -10.7% | -646,3 k € | -17.6% | -549,4 k € | +23.9% | -721,5 k € | -66.8% | -432,6 k € | -1666.4% | -24,5 k € | +33.5% | -36,8 k € | -122.9% | 160,6 k € | -2.9% | 165,4 k € | -34.2% | 251,4 k € | +196.4% | 84,8 k € | +74.4% | 48,6 k € | -63.4% | 133,1 k € | -36.5% | 209,4 k € | +134.7% | 89,2 k € | |
| Profit/loss | 152,1 k € | +101.5% | -9,9 M € | +10.6% | -11,1 M € | -465.2% | 3,0 M € | +190.6% | -3,3 M € | +84.9% | -22,2 M € | -919.3% | 2,7 M € | -22.3% | 3,5 M € | -14.1% | 4,1 M € | -9.3% | 4,5 M € | +42.1% | 3,2 M € | +3268.7% | 93,6 k € | -17.0% | 112,7 k € | +145.2% | 46,0 k € | +22.8% | 37,4 k € | -53.3% | 80,2 k € | -38.1% | 129,4 k € | +137.7% | 54,4 k € | |
| Equity | 182,0 M € | +0.1% | 181,8 M € | -5.2% | 191,7 M € | -8.4% | 209,4 M € | -1.6% | 212,8 M € | -4.8% | 223,6 M € | -14.4% | 261,2 M € | +1.0% | 258,5 M € | -8.4% | 282,3 M € | +1.5% | 278,3 M € | +1.6% | 273,8 M € | +18751.1% | 1,5 M € | +6.9% | 1,4 M € | +9.0% | 1,2 M € | +3.8% | 1,2 M € | +3.2% | 1,2 M € | +224.6% | 358,2 k € | +56.6% | 228,8 k € | |
| Total assets | 182,6 M € | +0.3% | 182,1 M € | -5.1% | 191,9 M € | -8.5% | 209,7 M € | -1.5% | 212,9 M € | -4.9% | 223,8 M € | -14.4% | 261,4 M € | +1.1% | 258,6 M € | -8.4% | 282,3 M € | +1.5% | 278,3 M € | +1.5% | 274,2 M € | +15740.2% | 1,7 M € | -8.6% | 1,9 M € | -5.0% | 2,0 M € | -8.9% | 2,2 M € | +16.8% | 1,9 M € | +35.4% | 1,4 M € | +19.6% | 1,2 M € | |
| Cash | 127,2 k € | +4.4% | 121,8 k € | +103.7% | 59,8 k € | -65.2% | 172,0 k € | -73.3% | 643,0 k € | +7.6% | 597,5 k € | +109.6% | 285,1 k € | -92.2% | 3,7 M € | -71.9% | 13,0 M € | +61.2% | 8,1 M € | +97.9% | 4,1 M € | +1092.9% | 342,3 k € | +168.1% | 127,7 k € | -44.8% | 231,3 k € | -10.9% | 259,5 k € | +87.6% | 138,4 k € | -27.6% | 191,0 k € | +50.4% | 127,0 k € | |
| Debts | 556,6 k € | +105.4% | 271,0 k € | +30.7% | 207,4 k € | -28.2% | 288,8 k € | +101.3% | 143,5 k € | -14.6% | 168,1 k € | -3.0% | 173,2 k € | +61.9% | 107,0 k € | +332.8% | 24,7 k € | -4.6% | 25,9 k € | -93.4% | 391,9 k € | +46.0% | 268,4 k € | -49.3% | 529,7 k € | -28.6% | 742,4 k € | -24.4% | 982,4 k € | +38.2% | 711,1 k € | -30.2% | 1,0 M € | +9.8% | 927,7 k € | |
| Staff | 2 | 2 | 2 | 2,3 | 2,5 | 2,5 | 2 | 1,9 | 1 | 1 | 10,6 | 10,1 | 10,6 | 9,4 | 8,7 | 9,8 | 9 | 8,7 | ||||||||||||||||||
Public limited company · Drogenbos · incorporated on 18/04/2000 · 2,0 ETP
Public limited company profitable and well capitalised.
Solid counterparty for a standard engagement.
LINVATEC BELGIUM is a Public limited company incorporated in 2000. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Drogenbos. It employs on average 2,0 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette